Stock Ideas
Stocks
Funds
Screener
Sectors
Watchlists
MGTX

MGTX - MeiraGTx Holdings plc Stock Price, Fair Value and News

5.00USD+0.01 (+0.20%)Delayed as of 18 Jul 2024, 11:58 am ET

Market Summary

MGTX
USD5.00+0.01
Delayedas of 18 Jul 2024, 11:58 am
0.20%

MGTX Stock Price

View Fullscreen

MGTX RSI Chart

MGTX Valuation

Market Cap

320.9M

Price/Earnings (Trailing)

-4.33

Price/Sales (Trailing)

28.2

EV/EBITDA

-3.52

Price/Free Cashflow

-2.72

MGTX Price/Sales (Trailing)

MGTX Profitability

EBT Margin

-599.46%

Return on Equity

-60.87%

Return on Assets

-23.96%

Free Cashflow Yield

-36.75%

MGTX Fundamentals

MGTX Revenue

Revenue (TTM)

11.4M

Rev. Growth (Yr)

-79.09%

Rev. Growth (Qtr)

-65.83%

MGTX Earnings

Earnings (TTM)

-74.1M

Earnings Growth (Yr)

32.68%

Earnings Growth (Qtr)

-201.12%

Breaking Down MGTX Revenue

52 Week Range

4.307.35
(Low)(High)

Last 7 days

20.8%

Last 30 days

13.9%

Last 90 days

-0.2%

Trailing 12 Months

-22.7%

How does MGTX drawdown profile look like?

MGTX Financial Health

Current Ratio

3.14

MGTX Investor Care

Shares Dilution (1Y)

8.08%

Diluted EPS (TTM)

-1.18

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
202411.4M000
202315.4M15.0M14.5M14.0M
202238.7M44.4M42.3M15.9M
202115.9M18.6M20.4M37.7M
202016.7M17.2M18.7M15.6M
201900013.3M

Tracking the Latest Insider Buys and Sells of MeiraGTx Holdings plc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Jun 05, 2024
indyk martin
acquired
-
-
20,000
-
Jun 05, 2024
harris keith r.
acquired
-
-
30,000
-
May 28, 2024
giroux richard
gifted
-
-
-3,000
cfo & coo
Apr 05, 2024
forbes alexandria
gifted
-
-
-1,000
president & ceo
Mar 12, 2024
forbes alexandria
gifted
-
-
-2,000
president & ceo
Feb 29, 2024
giroux richard
gifted
-
-
-13,500
cfo & coo
Jan 14, 2024
wollin robert j
sold (taxes)
-16,815
6.36
-2,644
general counsel and secretary
Jan 14, 2024
wollin robert j
acquired
-
-
5,000
general counsel and secretary
Jan 14, 2024
zeldin robert k
sold (taxes)
-93,848
6.36
-14,756
chief medical officer
Jan 14, 2024
zeldin robert k
acquired
-
-
37,500
chief medical officer

1–10 of 50

Which funds bought or sold MGTX recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jul 15, 2024
WASHINGTON TRUST Co
unchanged
-
-891
2,017
-%
Jul 11, 2024
SALEM INVESTMENT COUNSELORS INC
sold off
-100
-3,642
-
-%
Jul 10, 2024
CWM, LLC
new
-
-
-
-%
Jul 09, 2024
LAZARD ASSET MANAGEMENT LLC
reduced
-35.47
-18,000
21,000
-%
Jul 02, 2024
GAMMA Investing LLC
reduced
-46.78
-2,554
1,495
-%
Jul 01, 2024
Legal & General Group Plc
unchanged
-
-3,106
19,849
-%
May 21, 2024
China Universal Asset Management Co., Ltd.
added
66.52
22,333
74,333
0.01%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-66.05
-385,537
160,205
-%
May 16, 2024
Ancora Advisors LLC
unchanged
-
-523
3,338
-%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-38.9
-17,772
19,904
-%

1–10 of 47

Are Funds Buying or Selling MGTX?

Are funds buying MGTX calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own MGTX
No. of Funds

Unveiling MeiraGTx Holdings plc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
perceptive advisors llc
18.0%
11,442,562
SC 13D/A
Feb 13, 2024
prosight management, lp
6.4%
4,050,714
SC 13G/A
Feb 07, 2024
adage capital partners gp, l.l.c.
8.32%
5,291,618
SC 13G/A
Nov 06, 2023
sanofi
7.4%
4,697,737
SC 13G
May 16, 2023
perceptive advisors llc
19.1%
11,406,563
SC 13D/A
May 15, 2023
prosight management, lp
6.9%
4,078,804
SC 13G
Feb 14, 2023
orbimed advisors llc
0%
0
SC 13G/A
Feb 09, 2023
adage capital partners gp, l.l.c.
6.41%
3,105,800
SC 13G/A
Nov 14, 2022
johnson & johnson
13.7%
6,641,064
SC 13G/A
Feb 11, 2022
orbimed advisors llc
8.1%
3,593,966
SC 13G/A

Recent SEC filings of MeiraGTx Holdings plc

View All Filings
Date Filed Form Type Document
Jun 10, 2024
8-K
Current Report
Jun 07, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
Jun 06, 2024
4
Insider Trading
May 30, 2024
4
Insider Trading

Peers (Alternatives to MeiraGTx Holdings plc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
47.5B
6.8B
-10.05% 1.17%
-7.97
6.94
-64.45% -224.75%
30.4B
2.0B
52.57% 15.15%
-91.43
15.16
75.20% 68.82%
22.5B
216.3K
-0.77% 465779.94%
-2.5K
104.0K
- -8.13%
16.1B
2.5B
-0.42% -1.88%
78.24
6.5
13.74% 186.89%
14.7B
3.8B
4.18% 5.89%
19.67
3.89
8.58% 129.81%
MID-CAP
5.2B
107.9M
2.83% -13.90%
-9.58
48.09
54.84% -28.31%
4.8B
524.1M
-2.08% -1.27%
-11.49
9.15
394.93% 39.61%
4.0B
251.0M
10.21% 12.93%
-13.42
15.84
73.58% -86.73%
3.5B
240.7M
11.63% -19.92%
-7.36
12.77
-1.03% -213.92%
3.0B
813.8M
23.65% -44.38%
-1.8K
3.73
56.43% 98.83%
2.2B
996.6M
12.81% 95.44%
-5.58
2.23
-26.66% 65.49%
SMALL-CAP
2.0B
411.3M
12.73% 21.74%
30.67
4.86
60.38% -34.49%
628.7M
881.7K
33.07% 659.10%
-18.62
481.06
-77.61% 33.36%
287.1M
4.2M
23.94% 64.88%
-2.3
69.02
-66.30% 48.24%
18.5M
2.1M
-6.52% -81.14%
-0.8
7.61
-13.45% 69.54%

MeiraGTx Holdings plc News

Latest updates
Simply Wall St16 Jul 202404:04 pm

MeiraGTx Holdings plc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
Income Statement (Quarterly)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-65.8%697,0002,040,0005,103,0003,540,0003,334,0004,075,0004,816,00010,759,0005,633,00021,042,5006,948,0005,116,0004,595,0003,787,5005,092,0002,474,0004,210,0006,942,7343,582,5861,981,676784,960
Operating Expenses3.7%47,469,00045,794,00037,865,00032,325,00035,094,00035,767,00027,624,00034,517,00034,367,00028,733,00029,500,00025,599,00026,627,00017,006,50013,522,00027,699,00019,889,00012,386,07014,489,25623,208,92521,475,704
  S&GA Expenses8.4%13,147,00012,124,00010,009,00012,388,00012,772,00014,002,00010,762,00010,518,00011,268,00015,551,0007,887,00010,409,0009,918,00012,007,5008,896,00011,497,00011,806,00014,872,8419,874,81013,437,1718,499,475
  R&D Expenses1.9%34,322,00033,670,00027,856,00019,937,00022,322,00021,765,00016,862,00023,999,00023,099,00013,182,00021,613,00015,190,00016,709,0004,999,0004,626,00016,202,0008,083,000-2,486,7714,614,4469,771,75412,976,229
EBITDA Margin0.7%-4.04-4.07-6.48-6.48-6.56-6.62-0.88-0.88-1.01-1.05-1.97-2.22---------
Interest Expenses-5.8%3,250,0003,449,0003,381,0003,355,0003,060,0002,895,0001,892,00082,00077,000119,00059,00051,00059,00036,00035,00034,00034,00020,3019,2839,4549,574
Income Taxes--------------------338,670-91,390-
Earnings Before Taxes----------------6,431,727-25,417,934--5,050,991-10,799,524-20,913,802-
EBT Margin0%-5.99-5.99-8.21-7.95-7.70-7.47-1.13-1.07-1.23-1.27-2.33-2.57---------
Net Income-201.1%-20,442,00020,215,000-44,297,000-29,581,000-30,364,000-27,313,000-37,284,000-33,973,000-31,045,000-9,912,000-25,945,000-20,086,000-23,618,000-10,461,000-6,432,000-25,418,000-15,681,000-5,481,051-10,460,854-20,822,412-17,981,918
Net Income Margin-8.6%-6.51-5.99-9.08-8.32-8.35-8.14-2.66-2.27-2.25-2.11-3.92-3.26---------
Free Cashflow-118.3%-38,378,000-17,577,000-27,978,000-33,979,000-46,005,000-24,759,000-30,737,000-41,807,000-20,758,000-5,541,000-29,088,000-26,836,000---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-5.4%309327267310288318301252288320303327340364293291305324318253258
  Current Assets-6.5%149160104143121154155104143183177207230273218235251269271213231
    Cash Equivalents-8.0%11913063.0093.0069.0011611572.00114138144173199210179195211227253204227
  Net PPE-3.9%11111611211411310994.0091.0084.0076.0064.0055.0047.0044.0035.0028.0025.0024.0017.0016.0016.00
Liabilities-0.6%188189175187198200179110126135115121119125114118120133123124113
  Current Liabilities-29.1%48.0067.0064.0072.0081.0082.0072.0068.0066.0068.0060.0057.0054.0054.0047.0047.0043.0049.0039.0041.0033.00
Shareholder's Equity-11.9%12213892.0012490.00118123142161185188206221239179173185191195130144
  Retained Earnings-3.7%-574-554-574-530-500-470-442-405-371-340-330-304-284-261-250-244-218-203-197-187-166
  Additional Paid-In Capital0.8%700694659653587582550541534529521516511504431414401396390316312
Shares Outstanding1.1%64.0064.0060.0060.0049.0048.0045.0045.0045.0045.0044.0044.00---------
Float----260---243---459---285---511,316,440-
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-152.3%-36,700-14,547-24,414-29,012-37,392-16,267-20,726-27,807-8,29818,828-17,183-21,2619,086-29,562-9,141-12,880-12,384-21,971-18,405-21,74482,166
  Share Based Compensation0%6,9606,9607,0537,2716,4326,8056,9377,3037,5785,4255,3395,2034,8176,837-3,0005,6834,1985,5884,1132,935
Cashflow From Investing-46.6%27,34051,178-3,564-4,975-8,605-8,492-10,011-14,000-12,460-25,369-11,905-5,575-18,868-10,234-19,834-2,916-4,036-5,139-2,023-1,091-1,115
Cashflow From Financing-104.6%-1,27027,711-40457,947-1,23124,83372,949--2,5821,29554.0022313669,43713,132-6.0016546870,206-5.4777,566
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

MGTX Income Statement

2024-03-31
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS  
Service revenue - related party$ 697 
License revenue - related party $ 3,334
Total revenue6973,334
Operating expenses:  
General and administrative13,14712,772
Research and development34,32222,322
Total operating expenses47,46935,094
Loss from operations(46,772)(31,760)
Other non-operating income (expense):  
Foreign currency (loss) gain(535)3,857
Interest income1,097545
Interest expense(3,250)(3,060)
Gain on sale of nonfinancial assets29,018 
Fair value adjustments 54
Net loss(20,442)(30,364)
Other comprehensive income (loss):  
Foreign currency translation loss(1,691)(2,353)
Comprehensive loss(22,133)(32,717)
Net income (loss)$ (20,442)$ (30,364)
Basic net loss per ordinary share$ (0.32)$ (0.62)
Diluted net loss per ordinary share$ (0.32)$ (0.62)
Weighted-average number of ordinary shares outstanding, basic64,065,89548,638,151
Weighted-average number of ordinary shares outstanding, diluted64,065,89548,638,151

MGTX Balance Sheet

2024-03-31
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2024
Dec. 31, 2023
CURRENT ASSETS:  
Cash and cash equivalents$ 119,206$ 129,566
Accounts receivable - related party10,91510,138
Prepaid expenses5,0765,625
Tax incentive receivable13,17113,277
Other current assets9321,016
Total Current Assets149,300159,622
Property, plant and equipment, net111,412115,896
Intangible assets, net1,0381,118
Restricted cash1,0591,083
Other assets1,1381,917
Equity method and other investments6,7666,766
Right-of-use assets - operating leases, net14,83515,910
Right-of-use assets - finance leases, net23,68724,432
TOTAL ASSETS309,235326,744
CURRENT LIABILITIES:  
Accounts payable21,22316,042
Accrued expenses17,35342,639
Lease obligations, current4,1884,193
Deferred revenue - related party, current3,7722,926
Other current liabilities1,0071,278
Total Current Liabilities47,54367,078
Deferred revenue - related party53,33134,017
Lease obligations11,79612,952
Asset retirement obligations2,4402,401
Note payable, net72,39172,119
TOTAL LIABILITIES187,501188,567
SHAREHOLDERS' EQUITY:  
Ordinary Shares, $0.00003881 par value, 1,288,327,750 authorized, 64,298,691 and 63,601,015 shares issued and outstanding at March 31, 2024 and December 31, 2023, respectively22
Capital in excess of par value699,531693,841
Accumulated other comprehensive income(3,126)(1,435)
Accumulated deficit(574,673)(554,231)
Total Shareholders' Equity121,734138,177
TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY$ 309,235$ 326,744
MGTX
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited retinal diseases and large degenerative ocular diseases, neurodegenerative diseases, and xerostomia. Its programs in clinical development include Phase I/II clinical stage programs in achromatopsia, X-linked retinitis pigmentosa, and RPE65-deficiency; Phase I clinical trials for radiation-induced xerostomia; and Parkinson's program that has completed a Phase II trial. It has a research collaboration agreement with Janssen Pharmaceuticals, Inc. for the research, development, and commercialization of gene therapies for the treatment of inherited retinal disease. MeiraGTx Holdings plc was incorporated in 2015 and is based in New York, New York.
 CEO
 WEBSITEhttps://meiragtx.com
 INDUSTRYBiotechnology
 EMPLOYEES406

MeiraGTx Holdings plc Frequently Asked Questions


What is the ticker symbol for MeiraGTx Holdings plc? What does MGTX stand for in stocks?

MGTX is the stock ticker symbol of MeiraGTx Holdings plc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of MeiraGTx Holdings plc (MGTX)?

As of Wed Jul 17 2024, market cap of MeiraGTx Holdings plc is 320.89 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of MGTX stock?

You can check MGTX's fair value in chart for subscribers.

What is the fair value of MGTX stock?

You can check MGTX's fair value in chart for subscribers. The fair value of MeiraGTx Holdings plc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of MeiraGTx Holdings plc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for MGTX so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is MeiraGTx Holdings plc a good stock to buy?

The fair value guage provides a quick view whether MGTX is over valued or under valued. Whether MeiraGTx Holdings plc is cheap or expensive depends on the assumptions which impact MeiraGTx Holdings plc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for MGTX.

What is MeiraGTx Holdings plc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Jul 17 2024, MGTX's PE ratio (Price to Earnings) is -4.33 and Price to Sales (PS) ratio is 28.2. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. MGTX PE ratio will change depending on the future growth rate expectations of investors.